Predect
New models for preclinical evaluation of drug efficacy in common solid tumours
Site Search
Site Search
Displaying results 571 - 580 of 601
EMTRAIN
European Medicines Research Training Network
12th Edition - March 2012
Table of contents:
- IMI 5th Call officially launched
- 5th Call Open Info Day – presentations online
- DIA EuroMeeting a success for IMI
- Roch Doliveux named new Chair of IMI Governing Board
- Michel Goldman in Nature Medicine: PPPs need ‘honest brokering’
- Clinical Pharmacology & Therapeutics paper on IMI: full version now available
- IMI Scientific Committee welcomes five new members
- Rethink needed on IPR metrics, experts say
- IMI presentations at forthcoming conferences
- News from the projects
SafeSciMET
European Modular Education and Training Programme in Safety Sciences for Medicines
IMI topic webinars - European Lead Factory
Over 130 people attended the webinars IMI organised on the 5th Call for proposals on 5 and 20 March . During the webinars, the Topic Coordinator, Jörg Hüser of Bayer Healthcare, delivered the presentation of the Call Theme that he gave at the 5th Call Open Info Day . There was ...
11th Edition - February 2012
Table of contents:
IMI at the Drug Information Association (DIA) Annual EuroMeeting
IMI reached out to the more than 3 000 attendees at the DIA (Drug Information Association) Annual EuroMeeting , held in Copenhagen, Denmark from 26 to 28 March. At the exhibition IMI’s exhibition stand attracted hundreds of curious visitors, eager to find out more about IMI’s ...
10th Edition - January-February 2012
Table of contents:
Open Info Day: 5th Call for proposals
IMI held its Open Info Day on its 5th Call for proposals at the Crowne Plaza – Le Palace Hotel in Brussels , Belgium on Monday 27 February 2012. Over 200 people attended, representing all types of organisations including small and medium-sized enterprises (SMEs), academic and ...
9th Edition - December 2011
Table of contents:
- IMI improves funding rules and simplifies procedures
- IMI 5th call – preliminary outline of European lead factory topic released
- European Commission releases Horizon 2020
- Independent Observers: IMI 4th Call, Stage 1 evaluations conducted ‘independently and fairly’
- IMI on major international TV channel
- Michel Goldman discusses IMI at leading pharma conference
- IMI presentations at forthcoming conferences
- IMI Executive Office closed during the holiday period
- News from the projects